Gardner named CEO of Flagship’s Ampersand
Plus: Brian Powl joins Kura as CCO, and updates from BioNTech, Allogene, CG and more
Jason Gardner joined Flagship Pioneering as CEO-partner, while becoming CEO and board member at portfolio company Ampersand Biomedicines Inc. Gardner, a 10-year veteran of GSK plc (LSE:GSK; NYSE:GSK), was most recently president and CEO of Magenta Therapeutics Inc. (NASDAQ:MGTA), which he co-founded.
Brian Powl was named chief commercial officer (CCO) at Kura Oncology Inc. (NASDAQ:KURA), which is developing precision medicines for cancer. Powl was most recently CCO at Fate Therapeutics Inc. (NASDAQ:FATE)...